AbCellera Biologics Inc.
ABCL
Peringkat dalam Saham
#4170
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the... AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.
Harga Saham
$11.85
Terakhir disinkronkan: 2026-10-16
Kapitalisasi Pasar
$3.84B
Perubahan (1 hari)
-6.59%
Perubahan (1 tahun)
111.90%
Negara
CA
Perdagangan AbCellera Biologics Inc. (ABCL)
Kategori
Healthcare
EPS untuk AbCellera Biologics Inc. (ABCL)
EPS per June 2026 TTM: $-0.54
Menurut laporan keuangan terbaru dan harga saham AbCellera Biologics Inc., EPS perusahaan saat ini (TTM) adalah $-0.54. Pada akhir 2023, perusahaan memiliki EPS sebesar $-0.51 penurunan dibandingkan dengan EPS tahun 2022 sebesar $0.56.
Riwayat EPS untuk AbCellera Biologics Inc. dari 2018 hingga 2026
EPS di akhir setiap tahun
| Tahun | EPS | Mengubah |
|---|---|---|
| 2026 (TTM) | $-0.54 | -1.82% |
| 2024 | $-0.55 | 7.84% |
| 2023 | $-0.51 | -191.07% |
| 2022 | $0.56 | 0.00% |
| 2021 | $0.56 | 75.00% |
| 2020 | $0.32 | -3,206.80% |
| 2019 | $-0.01 | -615.00% |
| 2018 | 0.00 | 0.00% |
EPS untuk perusahaan sejenis atau pesaing
| Perusahaan | EPS | Perbedaan EPS | Negara |
|---|---|---|---|
| $17.32 | -3,307.41% |
US
|
|
| $-7.98 | 1,377.78% |
US
|
|
| $-5.29 | 879.63% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -5,237.04% |
NL
|
